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Peutz–Jeghers syndrome (PJS) is a disease of autosomal dominant
inheritance that is characterized by hamartomatous gastrointestinal
polyps and melanocytic pigmentation on the lips and perioral and
buccal regions. Several studies have been reported on PJS associ-
ated with cancers of the gastrointestinal tract, pancreas, breast,
ovary, uterine cervix and gallbladder (Giardiello et al, 1987;
Spigelman et al, 1989). The PJS gene has been mapped to chromo-
some 19p13.3 by comparative genomic hybridization and linkage
analysis in PJS patients (Hemminki et al, 1997). Recently, the
STK11 gene was identified, and truncating germline mutations of
STK11 have been reported in PJS patients (Hemminki et al,
1998;Jenne et al, 1998). The STK11 gene is identical to the previ-
ously cloned but poorly characterized gene, LKB1. LKB1 encodes
a serine/threonine kinase with high homology to the Xenopus
serine/threonine kinase XEEK1 (Su et al, 1996).
STK11 extends over 23 kb, is composed of nine exons and is
ubiquitously expressed in various adult human tissues. The fact
that STK11 is the first kinase-encoding gene associated with
hereditary cancers which display inactivating germline mutations
implies that the mutant proteins may affect the development of PJS
phenotypes. Although the mutation rate of the STK11 gene was
low, somatic mutations in the STK11 gene were detected in
sporadic colorectal carcinomas, gastric carcinomas and malignant
melanomas (Dong et al, 1998; Gruber et al, 1998; Park et al, 1998;
Guldberg et al, 1999). Together, these reports suggest that STK11
is a tumour suppressor gene and that genetic changes of STK11
play an important role in the development of cancer as well as
Peutz–Jeghers syndrome.
The present study screened a total of ten Korean PJS patients
including nine sporadic cases and one familial case to investigate
genetic alterations of the STK11 gene.
MATERIALS AND METHODS
Patients
Mutational analysis of the STK11 gene was performed with DNA
samples from ten Korean PJS patients: SNU-P2, SNU-P5, SNU-
P6, SNU-P7, SNU-P8, HYU-P2, HYU-P3, YSU-P5, USU-P1,
USU-P2. Among these patients, SNU-P5 is a familial case
including two PJS patients. For the family screening of SNU-P5, a
brother and a sister of the patients were available. Other family
members except the patients had no clinical signs of PJS. Clinical
manifestations of the patients with PJS were shown in Table 1. In
pathologic reports of all patients, hamartomatous polyps were
proven. The number of polyps was ranged from 5 to 200.
Mucocutaneous pigmentation was found in all patients. For
genetic polymorphism studies, we screened for the STK11 gene in
DNA samples obtained from peripheral blood lymphocytes of 60
healthy people and in normal colonic mucosa DNA samples from
40 colorectal cancer patients.
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Summary Peutz–Jeghers syndrome (PJS) is an autosomal dominantly inherited disease characterized by hamartomatous gastrointestinal
polyps and mucocutaneous pigmentation, with an increased risk for various neoplasms, including gastrointestinal cancer. Recently, the PJS
gene encoding the serine/threonine kinase STK11 (also named LKB1) was mapped to chromosome 19p13.3, and germline mutations were
identified in PJS patients. We screened a total of ten Korean PJS patients (nine sporadic cases and one familial case including two patients)
to investigate the germline mutations of the STK11 gene. By polymerase chain reaction–single-strand conformation polymorphism and DNA
sequencing analysis, three kinds of mis-sense mutation and a frame-shift mutation were identified: codon 232 (TCC to CCC) in exon 5, codon
256 (GAA to GCA) in exon 6, codon 324 (CCG to CTG) in exon 8, and a guanine insertion at codon 342 resulting in a premature stop codon
in exon 8. These mis-sense variants were not detected in 100 control DNA samples. Furthermore, we found an intronic mutation at the
dinucleotide sequence of a splice-acceptor site: a one base substitution from AG to CG in intron 1, which may cause aberrant splicing. Most
reported germline mutations of the STK11 gene in PJS patients were frame-shift or non-sense mutations resulting in truncated proteins.
Together, these findings indicate that germline mis-sense mutations of the STK11 gene are found in PJS patients in addition to truncating
mutations. The effects of these mutations on protein function require further examination. In summary, we found germline mutations of the
STK11 gene in five out of ten Korean PJS patients. © 2000 Cancer Research Campaign
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Peripheral blood lymphocytes were isolated using Ficoll-Paque
according to the manufacturer’s instructions (Pharmacia Biotech,
Uppsala, Sweden). Total genomic DNA of lymphocytes was
extracted using TRI reagent according to the manufacturer’s
instructions (Molecular Research Center, Cincinnati, OH, USA).
Normal colonic mucosa DNAs were extracted according to the
standard sodium dodecyl sulphate (SDS)–proteinase K procedure.
PCR amplification and single strand conformation
polymorphism
The polymerase chain reaction (PCR) primer pairs were used as
described by Jenne et al (1998). PCR reactions contained, in a
final reaction volume of 25 ml, 100 ng of genomic DNA, 2.5
pmoles of each primer, 250 mM of each dNTPs, and 0.5 units of
Taq DNA polymerase. The PCR reaction buffer and Q solution
were provided by the supplier (Qiagen, Hilden, Germany). PCR
reactions were initiated by denaturing the DNA for 5 min at 94°C
in a programmable thermal cycler (Perkin-Elmer Cetus 9600:
Roche Molecular Systems, Inc., NJ, USA). PCR cycles were: 35
cycles at 94°C for 30 s, 62°C for 1 min, and 72°C for 1 min, with a
final elongation for 10 min at 72°C.
For single-strand conformation polymorphism (SSCP), the
genomic DNA was amplified in a final volume of 10 ml. Each
exon of the STK11 gene underwent the same PCR procedure as
described above, with the addition of [a-32P]-dCTP (Amersham,
Arlington Heights, IL, USA). The region from exon 4 to exon 5
was amplified in a single PCR reaction and then digested with
MaeIII endonuclease (Boehringer Mannheim, Germany) at 55°C
for 2 h, whereas exons 1, 2, 3, 6, 7, 8 and 9 were amplified
separately.
Radiolabelled PCR reaction products were mixed with 95%
formamide dye, denatured at 94°C for 5 min and chilled on ice.
Three microlitres of each mixture was loaded onto a non-dena-
turing SSCP gel (6% polyacrylamide gel (19:1) with 10% glycerol
in 1 ´ TBE buffer) and separated for 12–16 h at room temperature
at a constant 300 V. After electrophoresis, the gel was transferred
to 3MM Whatman paper, dried on a gel dryer and subjected to
autoradiography.
Cloning and sequencing
Samples showing abnormal bands by SSCP were subjected to
cloning for DNA sequencing analysis. Fresh PCR products were
ligated into pCR®-TOPO vectors and subcloned using the TA
cloning system (Invitrogen, San Diego, CA, USA). A minimum of
ten individual colonies were selected and cultured overnight in LB
medium containing 50 mg ml–1 ampicillin. Plasmid DNAs were
isolated and used for DNA sequencing analysis. Bi-directional
sequencing analysis was performed using either the dideoxy chain
termination method with a T7 DNA polymerase sequencing kit
(Pharmacia Biotech Inc., Piscataway, NJ, USA) or the Taq dideoxy
terminator cycle sequencing kit on an ABI 377 DNA sequencer
(Perkin-Elmer, Foster City, CA, USA). Sequences of target DNA
were determined by using the original PCR primers.
RESULTS
To investigate the genetic alteration of the STK11 gene, we
screened nine exons by PCR-SSCP analysis in ten Korean PJS
patients. PCR-SSCP analysis revealed abnormal band shifts in
exon 5 in two patients (SNU-P5 and her sister). However, the
analysis revealed no abnormal bands in other samples, including
two normal family members of the SNU-P5. In exon 6, the SSCP
pattern of the SNU-P2 showed a different band pattern compared
to that of other patients and controls. In exon 8, abnormal SSCP
patterns were found in two unrelated patients (the SNU-P6 and the
HYU-P2). An abnormal SSCP band pattern in exon 2 was detected
in the USU-P2.
Sequencing analysis revealed three mis-sense mutations and a
frame-shift mutation in exons 5, 6 and 8. The SNU-P5 and her
sister had the same mis-sense mutation from TCC (Ser) to CCC
(Pro) at codon 232 in exon 5 (Figure 1A). This mutation was not
detected in other family members of SNU-P5. Two missense
mutations from GAA (Glu) to GCA (Ala) at codon 256 in exon 6
and from CCG (Pro) to CTG (Leu) at codon 324 in exon 8 were
identified in the SNU-P2 and the HYU-P2 respectively (Figure
1B). These mis-sense variants were not detected in DNA samples
from peripheral blood lymphocytes of 60 healthy people or in
normal colonic mucosa DNA from 40 colorectal cancer patients.
The SNU-P6 exhibited a frame-shift mutation by insertion of an
additional guanine at codon 342, resulting in a premature stop
codon in exon 8 (Figure 2). In the USU-P2, we found an intronic
mutation at a splice-acceptor sequence. The transversion from the
dinucleotide sequence AG to CG in intron 1 would theoretically
cause aberrant splicing that may result in a truncated protein.
However, we could not confirm the occurrence of aberrant
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Table 1 Clinical manifestations of patients with Peutz–Jeghers syndrome
1st symptom Mucocutaneous Distribution of Number of Family Laparotomy
Patient Sex/Age (age) pigmentation polyp polyp history (´ Numbera)
SNU-P2 M/49 8 Yes SB, CR 45 No Yes (´3)
SNU-P5 F/36 19 Yes SB, CR 67 Yes Yes (´4)
F/31 16 Yes SB, CR @100 Yes Yes (´2)
SNU-P6 M/23 18 Yes ST, SB, CR 50 No Yes (´1)
SNU-P7 M/31 12 Yes SB, CR 30 No Yes (´3)
SNU-P8 F/28 25 Yes ST, SB, CR 10 No Yes (´1)
HYU-P2 F/25 21 Yes ST, SB, CR 100–200 No Yes (´2)
HYU-P3 M/26 11 Yes ST, SB, CR 100–200 No Yes (´2)
YSU-P5 F/28 22 Yes ST, SB @100 No Yes (´2)
USU-P1 M/22 16 Yes SB, CR 5 No No
USU-P2 F/29 15 Yes ST, SB, CR @100 No Yes (´2)
M, male; F, female; ST, stomach; SB, small bowel; CR, colorectum. aEndoscopic polypectomy was not included.splicing due to a lack of available mRNA. The results of these
mutational analyses are summarized in Table 2.
DISCUSSION
Three mis-sense mutations, a frame-shift mutation and an intronic
mutation at a splice-acceptor site were identified in five out of the
ten Korean PJS patients we examined. Most germline mutations
reported of the STK11 gene in PJS patients were either frame-shift
or non-sense mutations resulting in truncated proteins (Gruber et
al, 1998; Hemminki et al, 1998; Jenne et al, 1998; Nakagawa et al,
1998). All mutations of STK11 that lead to truncated proteins with
incomplete catalytic domains are unlikely to exhibit kinase activity
(Jenne et al, 1998). The SNU-P6 exhibited a frame-shift mutation
of STK11 which resulted in a premature stop codon in exon 8. The
USU-P2 showed an intronic mutation at a splice-acceptor site in
intron 1 that may cause aberrant splicing and a truncated protein.
In this splice acceptor site, three kinds of germline mutation were
reported in PJS patients by other groups (Nakagawa et al, 1998;
Westerman et al, 1999). Therefore, STK11 is thought to lose its
serine/threonine kinase function due to a truncated gene product,
promoting the development of the PJS phenotype.
Three of the five mutations we detected were mis-sense muta-
tions. Only 16% of previously reported germline mutations in
STK11 in PJS patients were of the mis-sense type, although mis-
sense mutations have been detected in sporadic colon and stomach
cancers (Dong et al, 1998; Park et al, 1998; Hemminki, 1999). The
three mis-sense mutations of STK11 we found occurred in codons
232, 256 and 324. Codons 37–314 of STK11 share 93% homology
with Xenopus early embryonic kinase 1, XEEK1 (GenBank acces-
sion no. U24435) and 96% homology with mouse Lkb1 (GenBank
accession no. AF145287), as well as these three codons (232, 256,
324) are identical with those of XEEK1 and mouse Lkb1 (Smith
et al, 1999). Moreover, the catalytic core of the presumed kinase
domain of STK11 is located between codons 50 and 337
(Hemminki et al, 1998; Jenne et al, 1998). Therefore, we suspect
that these mis-sense mutations we found could affect the function
of STK11 through alteration of the kinase domain. Among the
family members of the SNU-P5, her sister is another PJS patient.
Because these two sisters shared the same mutation in exon 5 of
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Figure 1 The mis-sense mutations of the STK11 gene in the germline. Mis-sense mutations in exon 5 of two patients (the SNU-P5 and her sister) (A) and
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Figure 2 The frame-shift mutation of the STK11 gene in the germline.
Frame-shift mutation in exon 8 of STK11 of the SNU-P6. The guanine
insertion at codon 342 results in a truncating mutation at codon 359
Table 2 Germline mutations of the STK11 gene in Korean PJS families
Patient Location Codon Nucleotide change Predicted effect
SNU-P2 Exon 6 256 GAA®GCA Glu®Ala
SNU-P5 Exon 5 232 TCC®CCC Ser®Proa
SNU-P6 Exon 8 342 G insertion Premature stop
GAG®GGAG at codon 359
HYU-P2 Exon 8 324 CCG®CTG Pro®Leu
USU-P2 Intron 1 ccagGG®cccgGG Aberrant splicing?
aTwo patients (SNU-P5 and her sister) shared the same mutation in exon 5 of the STK11 gene.the STK11 gene, we concluded that this mis-sense mutation exhib-
ited penetrance in these patients. To exclude the possibility that
these mutations were genetic polymorphisms, we screened exons
5, 6 and 8 of STK11 in blood DNA samples of 60 healthy people
and in normal mucosal tissue DNA from 40 colon cancer patients.
Because the results of SSCP in these controls proved to be normal,
the mutations detected in PJS patients were not considered poly-
morphic variants but germline mutations or rare polymorphisms of
the  STK11 gene. The effects of these mis-sense mutations on
STK11 functional activity require further examination, and are the
subject of future studies.
Members of PJS families are at risk of developing
Peutz–Jeghers syndrome. Thus, it may be more feasible to offer
predictive genetic testing to members of PJS families instead of
repeated physical examinations (Nakagawa et al, 1998). Five out
of ten Korean PJS patients we examined had germline mutations
of the STK11 gene. Owing to the high rate of germline mutation in
the STK11 gene in PJS patients, screening for STK11 mutations in
PJS patients should be used as a diagnostic tool.
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